Biofab Pharma Private Limited
About Biofab Pharma Private Limited
Data last updated:
Biofab Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 28 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC340062. Its GSTIN is 27AAJCB0109P1ZJ (Maharashtra).
The company has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000. It is led by directors including Mohd Talib Mohd Tahir Usmani and Nausherali Rogangar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Plot No 14/E/1 Road No.3 Near Hari Masjid Govandi Shivaji Nagar, Mumbai, Maharashtra, India – 400043.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.85 Lakh. For the same year it recorded a net profit of ₹37,233 (net margin 2.9%) and EBITDA of ₹37,983 (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years.
Company details
Contact details
Biofab Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address1st Floor Plot No 14/E/1 Road No.3 Near Hari Masjid Govandi Shivaji Nagar, Mumbai, Maharashtra, India – 400043
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Biofab Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biofab Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biofab Pharma Private Limited, buy the company report.
Financials of Biofab Pharma Private Limited
FY 2025 filings availableBiofab Pharma Private Limited reported revenue of ₹12.85 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over three years. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37,983 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37,233 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biofab Pharma Private Limited, buy the company report.
Board of directors of Biofab Pharma Private Limited
Biofab Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Talib Mohd Tahir Usmani | Director | 20 Jul 2020 | 6 Years 3 Months | Current |
| Nausherali Rogangar | Director | 28 May 2020 | 6 Years 4 Months | Current |
| Namrah Nausher Rogangar | Director | 28 May 2020 | 6 Years 4 Months | Current |
Peer comparison
Biofab Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| C.S. Organic Millet Foods Private Limited | ₹12.86 Lakh (FY 2019) | 135.0% | West Mambalam, Tamil Nadu, India | |||
| Coolcent Coolants Pvt Ltd | ₹12.86 Lakh (FY 2025) | 16.0% | Ahmedabad, Gujarat, India | |||
| Zebwell Healthcare Private Limited | ₹12.85 Lakh (FY 2023) | 39.0% | Cuttack, Odisha, India | |||
| Kritya Network Private Limited | ₹12.85 Lakh (FY 2021) | Delhi, India | ||||
| Cirus Solar Private Limited | ₹12.85 Lakh (FY 2020) | -81.0% | Hyderabad, Telangana, India | |||
| Biofab Pharma Private Limitedthis company | ₹12.85 Lakh (FY 2025) | ₹37,233 | 2.9% | Mumbai, Maharashtra, India | ||
| Maa-Jee Marketings Private Limited | ₹12.85 Lakh (FY 2020) | 206493.0% | Dhule, Maharashtra, India | |||
| Jalna Re-Rolling Mill Private Limited | ₹12.85 Lakh (FY 2023) | Jalna, Maharashtra, India | ||||
| Imart Marketing Private Limited | ₹12.85 Lakh (FY 2024) | -27.0% | Patna, Bihar, India | |||
| Mcwang's Private Limited | ₹12.85 Lakh (FY 2022) | 19.0% | Imphal, Manipur, India | |||
| Acecode Technologies (OPC) Private Limited | ₹12.84 Lakh (FY 2019) | Delhi, India |
To see the full peer comparison of Biofab Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biofab Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biofab Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Biofab Pharma Private Limited has 1 active EPFO establishment as of Apr 11, 2024.
GST
Biofab Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCB0109P1ZJ | Maharashtra | Active | 25 Jul 2021 |
To see the full GST registrations and return filing status of Biofab Pharma Private Limited, buy the company report.
Recent activity
Biofab Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Mohd Talib Mohd Tahir Usmani ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Biofab Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 28 May 2020 (6+ years old) and is registered under CIN U74999MH2020PTC340062.
Biofab Pharma has 3 current directors:
- Mohd Talib Mohd Tahir Usmani - Director
- Nausherali Rogangar - Director
- Namrah Nausher Rogangar - Director
The latest financial statements of Biofab Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Biofab Pharma is 27AAJCB0109P1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Biofab Pharma is U74999MH2020PTC340062. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biofab Pharma was incorporated on 28 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Biofab Pharma by revenue are C.S. Organic Millet Foods Private Limited, Coolcent Coolants Pvt Ltd, Zebwell Healthcare Private Limited, Kritya Network Private Limited, Cirus Solar Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mohd Talib Mohd Tahir Usmani ceased to be Additional Director on 30 Sep 2022. Mohd Talib Mohd Tahir Usmani was appointed as Director on 20 Jul 2020. Namrah Nausher Rogangar was appointed as Director on 28 May 2020. Biofab Pharma has 4 board changes on record in total.
The registered office of Biofab Pharma is at 1st Floor Plot No 14E1 Road No.3 Near Hari Masjid Govandi Shivaji Nagar, Mumbai, Maharashtra, India – 400043.
Biofab Pharma operates in the business services industry, in the other services segment.
Biofab Pharma can be reached at its registered office: 1st Floor Plot No 14E1 Road No.3 Near Hari Masjid Govandi Shivaji Nagar, Mumbai, Maharashtra, India – 400043.